During the past decade, Rush Pain Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rush Pain Center" are "Migraine" (1 trials) and "Post-Operative Pain" (1 trials). Many other conditions were trialed in "Rush Pain Center" in a lesser frequency.

Most popular intervention types in "Rush Pain Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Sufentanil NanoTab PCA System" (1 trials), "Precision" (1 trials) and "Sufentanil NanoTab PCA System/15 mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush Pain Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rush Pain Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rush Pain Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush Pain Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".